Foamix Announces FMX101 Topical Minocycline Foam For Moderate-to-Severe Acne Met Both Co-Primary Endpoints and Demonstrated Highly Statistically Significant Improvement In Inflammatory Lesions In Third Phase 3 Trial
Benzinga_Newsdesk